Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetic aspects of retinal drug delivery
Eva M. del Amo, Anna‐Kaisa Rimpelä, Emma M. Heikkinen, et al.
Progress in Retinal and Eye Research (2016) Vol. 57, pp. 134-185
Open Access | Times Cited: 545

Showing 1-25 of 545 citing articles:

Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter, Greg A. Lazar
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 3, pp. 197-223
Closed Access | Times Cited: 670
Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration
Kai Kaarniranta, Hannu Uusitalo, Janusz Błasiak, et al.
Progress in Retinal and Eye Research (2020) Vol. 79, pp. 100858-100858
Open Access | Times Cited: 359
Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
Rubén Varela‐Fernández, Victoria Díaz-Tomé, Andrea Luaces-Rodríguez, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 269-269
Open Access | Times Cited: 264
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
Priyatham S. Mettu, Michael J. Allingham, Scott W. Cousins
Progress in Retinal and Eye Research (2020) Vol. 82, pp. 100906-100906
Open Access | Times Cited: 241
Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties
Astrid Subrizi, Eva M. del Amo, Viktor Korzhikov‐Vlakh, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 8, pp. 1446-1457
Open Access | Times Cited: 181
Principles of pharmacology in the eye
Sahar Awwad, Abeer H. A. Mohamed-Ahmed, Garima Sharma, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 23, pp. 4205-4223
Open Access | Times Cited: 175
Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”
Francis L. Munier, Maja Beck‐Popovic, Guillermo Chantada, et al.
Progress in Retinal and Eye Research (2019) Vol. 73, pp. 100764-100764
Open Access | Times Cited: 175
Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins
Armin Vedadghavami, Chenzhen Zhang, Ambika G. Bajpayee
Nano Today (2020) Vol. 34, pp. 100898-100898
Open Access | Times Cited: 151
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Hyeong Min Kim, Se Joon Woo
Pharmaceutics (2021) Vol. 13, Iss. 1, pp. 108-108
Open Access | Times Cited: 140
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Jingfa Zhang, Jingxiang Zhang, Chaoyang Zhang, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3362-3362
Open Access | Times Cited: 138
Hyaluronic acid in ocular drug delivery
Xiaodan Zhang, Dan‐Yi Wei, Yang Xu, et al.
Carbohydrate Polymers (2021) Vol. 264, pp. 118006-118006
Closed Access | Times Cited: 133
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
Kalyan Dulla, Ralph Slijkerman, Hester C. van Diepen, et al.
Molecular Therapy (2021) Vol. 29, Iss. 8, pp. 2441-2455
Open Access | Times Cited: 104
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances
Shery Jacob, Anroop B. Nair, Jigar Shah, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 533-533
Open Access | Times Cited: 97
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Shiding Li, Liangbo Chen, Yao Fu
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 87
Drug Delivery Systems in Regenerative Medicine: An Updated Review
Alaa Mansour, Maya Romani, Anirudh B. Acharya, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 695-695
Open Access | Times Cited: 67
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases
Chuhan Wang, Yan Pang
Advanced Drug Delivery Reviews (2023) Vol. 194, pp. 114721-114721
Closed Access | Times Cited: 54
Overview of Recent Advances in Nano-Based Ocular Drug Delivery
L Liu, Yi‐Hao Chen, Da‐Wen Lu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15352-15352
Open Access | Times Cited: 42
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications
Karim Soliman, Kaleem Ullah, Ankit Shah, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 8, pp. 1575-1586
Open Access | Times Cited: 144
The effects of PEGylation on LNP based mRNA delivery to the eye
Renee C. Ryals, Siddharth Patel, Chris Acosta, et al.
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0241006-e0241006
Open Access | Times Cited: 136
New concepts in the diagnosis and management of choroidal metastases
Thibaud Mathis, P. Jardel, Olivier Loria, et al.
Progress in Retinal and Eye Research (2018) Vol. 68, pp. 144-176
Open Access | Times Cited: 133
Polysaccharides in Ocular Drug Delivery
Natallia V. Dubashynskaya, Daria N. Poshina, Sergei V. Raik, et al.
Pharmaceutics (2019) Vol. 12, Iss. 1, pp. 22-22
Open Access | Times Cited: 124
Exploring the Impact of Morphology on the Properties of Biodegradable Nanoparticles and Their Diffusion in Complex Biological Medium
Roxane Ridolfo, Shirin Tavakoli, Vijayabhaskarreddy Junnuthula, et al.
Biomacromolecules (2020) Vol. 22, Iss. 1, pp. 126-133
Open Access | Times Cited: 121
Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle
Jae Hwan Jung, Bryce Chiang, Hans E. Grossniklaus, et al.
Journal of Controlled Release (2018) Vol. 277, pp. 14-22
Open Access | Times Cited: 115
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
Laura García‐Quintanilla, Andrea Luaces-Rodríguez, María Gil‐Martínez, et al.
Pharmaceutics (2019) Vol. 11, Iss. 8, pp. 365-365
Open Access | Times Cited: 115
Intravitreal hydrogels for sustained release of therapeutic proteins
Blessing C. Ilochonwu, Arto Urtti, Wim E. Hennink, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 419-441
Open Access | Times Cited: 110
Page 1 - Next Page

Scroll to top